TAYLOR EVES: Open Payments
NPI 1225428063 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 50 payments from 12 companies in 2025. Trend: 2023 $3,179 · 2024 $2,786 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $249 |
| PFIZER INC. | 12 | $199 |
| Lilly USA, LLC | 8 | $110 |
| Organon LLC | 7 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Dexcom, Inc. | 1 | $20 |
| LEO Pharma Inc. | 1 | $17 |
| UCB, Inc. | 1 | $16 |
| Biogen, Inc. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
Products named: TREMFYA, LITFULO, MOUNJARO, CIBINQO, TALTZ, Dexcom G6 Transmitter, VTAMA, ADBRY.
Industry payments across OK — which companies pay providers there.
